{Reference Type}: Editorial
{Title}: This month in JAAD Case Reports: July 2024: Roflumilast, Ruxolitinib, and a New Editor.
{Author}: Sloan B;
{Journal}: J Am Acad Dermatol
{Volume}: 0
{Issue}: 0
{Year}: 2024 May 4
{Factor}: 15.487
{DOI}: 10.1016/j.jaad.2024.05.001